Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide efficacy study in children with autism
2009-010393-38Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of bumetanide in Autism Spectrum Disorder (ASD), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Change in Childhood Autism Rating Scale score. Started Aug 2009; status: active.
02
Drugs
bumetanide
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2009-010393-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010393-38.